Warden Bio
Warden Bio is developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs). The GSD gene therapy is based on research led by the lab…
Xilis
Cancer is the second leading cause of death in the U.S and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to…
ZealCare
ZealCare aims to improve the health and well-being of people with complex chronic diseases. The company licenses Duke’s Personalized Health Planning within Shared Medical Appointments…
Zenalux Biomedical
Zenalux Biomedical is developing novel biophotonic-based tools to aid in the diagnosis and treatment of cancer as well as other disease states. The company’s flagship…